Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.

autoencoder cancer subtypes deep neural network machine learning somatic mutations

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 19 07 2024
revised: 06 08 2024
accepted: 12 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

(1) Background: The identification of tumor subtypes is fundamental in precision medicine for accurate diagnoses and personalized therapies. Cancer development is often driven by the accumulation of somatic mutations that can cause alterations in tissue functions and morphologies. In this work, a method based on a deep neural network integrated into a network-based stratification framework (D3NS) is proposed to stratify tumors according to somatic mutations. (2) Methods: This approach leverages the power of deep neural networks to detect hidden information in the data by combining the knowledge contained in a network of gene interactions, as typical of network-based stratification methods. D3NS was applied using real-world data from The Cancer Genome Atlas for bladder, ovarian, and kidney cancers. (3) Results: This technique allows for the identification of tumor subtypes characterized by different survival rates and significant associations with several clinical outcomes (tumor stage, grade or response to therapy). (4) Conclusion: D3NS can provide a base model in cancer research and could be considered as a useful tool for tumor stratification, offering potential support in clinical settings.

Identifiants

pubmed: 39199616
pii: cancers16162845
doi: 10.3390/cancers16162845
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Matteo Valerio (M)

Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Alessandro Inno (A)

Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Alberto Zambelli (A)

Medical Oncology Unit, IRCCS Istituto Clinico Humanitas and Department of Biomedical Sciences, Humanitas University, 20089 Rozzano, Milan, Italy.

Laura Cortesi (L)

Oncology, Hematology, and Respiratory Diseases, Azienda Ospedaliera-Universitaria, Policlinico di Modena, 41124 Modena, Italy.

Domenica Lorusso (D)

Gynecologic Oncology Unit, Humanitas San Pio X, Milan and Humanitas University, Pieve Emanuele, 20090 Milan, Italy.

Valeria Viassolo (V)

Medical Genetics, Medical Direction, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Matteo Verzè (M)

Medical Direction, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Fabrizio Nicolis (F)

Medical Direction, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Stefania Gori (S)

Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.

Classifications MeSH